Elizabeth D. Barnett, MD
Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, Boston University




For more than 25 years at BUSM/BMC, Dr. Barnett has been a clinical and academic leader who has achieved international prominence in Travel and Tropical Medicine with a particular focus on refugee health and the medical needs of new immigrant families. She has served as the PI of the BMC Refugee Health Assessment Program for more than 20 years and also is Site Director for the GeoSentinel Program in partnership with the Centers for Disease Control. In addition, Dr. Barnett has studied the safety and dissemination of childhood immunizations and is a leader in the BMC Center for Immunization Safety and Assessment.

Nationally recognized for her work in Pediatric Infectious Diseases, Dr. Barnett is a member of the Committee on Infectious Diseases of the American Academy of Pediatrics, the body that publishes the Red Book, which is the authoritative text for the treatment of Pediatric Infectious Diseases. She has published more than 90 peer-reviewed manuscripts and presented at numerous national and international meetings and seminars.

Dr. Barnett completed her pediatric residency at Boston City Hospital (BCH) and Children’s Hospital, Boston. After serving as a Chief Resident in the Department of Pediatrics, she completed fellowship training in Pediatric Infectious Diseases at BCH under the direction of Drs. Pelton and Jerome Klein.


A Phase lll Randomized, Double-blind, Placebo-Controlled Three-Lot Consistency Study in Healthy Adult Volunteers to Assess Immunogenicity, and Clinical Acceptability of a Single-dose of the Live Oral
03/06/2014 - 03/05/2017 (PI)
PaxVax, Inc.


A Phase lll Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200
11/01/2013 - 10/31/2016 (PI)
PaxVax, Inc.


A Multicenter, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability pharmacokinetics an efficacy of ceftaroline versus cetriaxone in pediatric subjects with compli
01/01/2013 - 06/30/2015 (PI)
Cerexa, Inc.


A multi-center, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability, pharmacokinetics and efficacy of ceftaroline versus cetriaxone plus vancomycin in pediatric
10/01/2012 - 09/30/2013 (PI)
Cerexa, Inc.


Long Term Immunity and Safety following Vaccination with the Japanese Ecephalitis Vaccine IC51 in a Pediatric Population in Non-endemic Countries
12/12/2011 - 12/11/2012 (PI)
Intercell AG


IMMUNOGENICITY AND SAFETY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO, JESPECT) IN A PEDIATRIC POPULATION IN NON-ENDEMIC COUNTRIES. UNCONTROLLED, OPEN-LABEL PHASE 3 STUDY
02/01/2010 - 06/30/2012 (PI)
Intercell AG


Evaluation of Impact of Antimicrobial Therapy on Carriage of Susceptible and Resistant Streptococcus Pneumoniae
09/01/1999 - 06/30/2004 (PI)
SmithKline Beecham

Use of Intrapulmonary Percussive Ventilation to Prevent Respiratory Disease in Adolescents with Impaired Pulmonary Function
09/01/1999 - 08/31/2000 (PI)
Deborah Munroe Noonan Memorial Fund Medical Fdn Inc


A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALT
03/08/2021 - 03/08/2024 (PI)
Pfizer, Inc

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY OF A 20-VALENT…
06/29/2020 - 06/28/2023 (PI)
Pfizer, Inc

A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY…
05/29/2020 - 05/28/2023 (PI)
Pfizer, Inc

A Phase 3, Randomized, Double- or Observer-Blinded, Placebo Controlled Trial to Evaluate the…
03/09/2020 - 03/09/2023 (PI)
Pfizer, Inc

ThreeWire BAA/Secondment Agreement
10/07/2019 - 10/06/2022 (PI)
ThreeWire Inc.

Clinical Immunization Safety Assessment (CISA) Project - Clinical Consult Contributing
09/29/2017 - 09/28/2022 (PI)
CDC

A PHASE 2b, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY…
08/22/2019 - 08/21/2022 (PI)
Pfizer, Inc

CISA COVID
09/17/2020 - 03/31/2022 (PI)
CDC

Refugee And Immigrant Health P
01/01/1992 - 06/30/2020 (PI)
DPH DHHS

FLUAD vs Fluzone High-Dose Study (Contributing)
09/29/2016 - 09/28/2019 (PI)
CDC

Showing 10 of 15 results. Show All Results

Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Eimer J, Patimeteeporn C, Jensenius M, Gkrania-Klotsas E, Duvignaud A, Barnett ED, Hochberg NS, Chen LH, Trigo-Esteban E, Gertler M, Greenaway C, Grobusch MP, Angelo KM, Hamer DH, Caumes E, Asgeirsson H. Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020. J Travel Med. 2021 Aug 27; 28(6).View Related Profiles. PMID: 33987682
     
  2. Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746.View Related Profiles. PMID: 33853145
     
  3. Schmader KE, Liu CK, Harrington T, Rountree W, Auerbach H, Walter EB, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Wodi P, Broder KR. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2021 01 04; 4(1):e2031266. PMID: 33443580; PMCID: PMC7809592; DOI: 10.1001/jamanetworkopen.2020.31266;
     
  4. Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, Wachman EM. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020 10; 100:69-74.View Related Profiles. PMID: 32862058; PMCID: PMC7445146; DOI: 10.1016/j.placenta.2020.08.015;
     
  5. Taucher C, Barnett ED, Cramer JP, Eder-Lingelbach S, Jelinek T, Kadlecek V, Kiermayr S, Mills DJ, Pandis D, Reiner D, Dubischar KL. Neutralizing antibody persistence in pediatric travelers from non-JE-endemic countries following vaccination with IXIARO® Japanese encephalitis vaccine: An uncontrolled, open-label phase 3 follow-up study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101616. PMID: 32156630
     
  6. Gautret P, Angelo KM, Asgeirsson H, Duvignaud A, van Genderen PJJ, Bottieau E, Chen LH, Parker S, Connor BA, Barnett ED, Libman M, Hamer DH. International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study. Travel Med Infect Dis. 2019 Nov 09; 101504.View Related Profiles. PMID: 31707112; PMCID: PMC7110217; DOI: 10.1016/j.tmaid.2019.101504;
     
  7. Angelo KM, Libman M, Gautret P, Barnett E, Grobusch MP, Hagmann SHF, Gobbi F, Schwartz E, van Genderen PJJ, Asgeirsson H, Hamer DH. The rise in travel-associated measles infections-GeoSentinel, 2015-2019. J Travel Med. 2019 Sep 02; 26(6).View Related Profiles. PMID: 31218359; PMCID: PMC6816286; DOI: 10.1093/jtm/taz046;
     
  8. Kohl SE, Barnett ED. What do we know about travel for children with special health care needs? A review of the literature. Travel Med Infect Dis. 2020 Mar - Apr; 34:101438. PMID: 31233860
     
  9. Epstein RL, Bhagavathula M, Saag LA, Verma S, Kan CK, Mesick J, Kamineni P, White LF, Barnett ED, Salgame P, Hochberg NS. QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA. Int J Tuberc Lung Dis. 2019 04 01; 23(4):482-490.View Related Profiles. PMID: 31064628; PMCID: PMC6690781; DOI: 10.5588/ijtld.18.0540;
     
  10. Schlagenhauf P, Grobusch MP, Hamer DH, Asgeirsson H, Jensenius M, Eperon G, Rothe C, Isenring E, Fehr J, Schwartz E, Bottieau E, Barnett ED, McCarthy A, Kelly P, Schade Larsen C, van Genderen P, Stauffer W, Libman M, Gautret P. Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis. Malar J. 2018 Nov 29; 17(1):443.View Related Profiles. PMID: 30497487; PMCID: PMC6267801; DOI: 10.1186/s12936-018-2586-9;
     
Showing 10 of 103 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 103 publications over 30 distinct years, with a maximum of 11 publications in 2013

YearPublications
19911
19923
19931
19943
19952
19961
19972
19982
19992
20004
20011
20022
20034
20043
20054
20073
20083
20092
20106
20112
20127
201311
20144
20153
20164
20178
20186
20194
20202
20213
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Travel and Tropical Medicine
refugee health
immigrant health
Pediatric Infectious Diseases
Contact for Mentoring:

774 Albany St
Boston MA 02118
Google Map


Barnett's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department